Abstract | BACKGROUND: METHODS: This study used data from the Atherosclerosis Risk in Communities study. Cardiac biomarkers were measured from stored plasma samples collected at Visit 2 (1991-1993). Frailty was recorded at Visit 5 (2011-2013). Cox regression models were used to determine the association of cardiac biomarkers with frailty risk. RESULTS: Overall, 360/5199 (6.9%) participants aged 55.1 ± 5.1 years developed frailty during a median follow-up of 21.7 years. The incidence of frailty was significantly higher in participants with hs-cTnT ≥14 ng/L (vs. < 14 ng/L: 17.9% vs. 6.7%) or NT-proBNP ≥300 pg/ml (vs. < 300 pg/ml: 19.7% vs. 6.8%) (all P < 0.001). Comparing higher vs. lower cut-off levels of either hs-cTnT (14 ng/l) or NT-proBNP (300 pg/ml) demonstrated a greater than two-fold higher frailty risk, with hazard ratios (HRs) of 2.13 (95% confidence interval (CI): 1.130-4.01, P = 0.020) and 2.61 (95% CI: 1.28-5.33, P = 0.008), respectively. Individuals with both elevated hs-cTnT and NT-proBNP had a higher frailty risk than those without it (HR: 4.15; 95% CI: 1.50-11.48, P = 0.006). CONCLUSIONS: High hs-cTnT and NT-proBNP levels are strongly associated with incident frailty in the community-dwelling population without known CVD. Subclinical cardiac damage (hs-cTnT) and/or wall strain ( NT-proBNP) may be the key pathway of CVD patients developing frailty. Detection of hs-cTnT and NT-proBNP may help for early screening of high-risk frailty and providing individualised intervention. TRIAL REGISTRATION: URL: https://www. CLINICALTRIALS: gov ; Unique identifier: NCT00005131 .
|
Authors | Yu Jia, Dongze Li, Jing Yu, Yi Liu, Fanghui Li, Wentao Li, Qin Zhang, Yongli Gao, Wei Zhang, Zhi Zeng, Rui Zeng, Xiaoyang Liao, Qian Zhao, Zhi Wan |
Journal | BMC geriatrics
(BMC Geriatr)
Vol. 22
Issue 1
Pg. 321
(04 12 2022)
ISSN: 1471-2318 [Electronic] England |
PMID | 35413794
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2022. The Author(s). |
Chemical References |
- Biomarkers
- Peptide Fragments
- Troponin T
- Natriuretic Peptide, Brain
|
Topics |
- Atherosclerosis
(diagnosis, epidemiology)
- Biomarkers
- Cardiovascular Diseases
(diagnosis, epidemiology)
- Frailty
(complications, diagnosis, epidemiology)
- Humans
- Natriuretic Peptide, Brain
- Peptide Fragments
- Risk Factors
- Troponin T
|